These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 29102832)

  • 1. Postneonatal mortality impacts following grants from the Gavi Vaccine Alliance: an econometric analysis from 2000 to 2014.
    Kolesar RJ; Audibert M
    Public Health; 2017 Dec; 153():163-171. PubMed ID: 29102832
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gavi's Transition Policy: Moving From Development Assistance To Domestic Financing Of Immunization Programs.
    Kallenberg J; Mok W; Newman R; Nguyen A; Ryckman T; Saxenian H; Wilson P
    Health Aff (Millwood); 2016 Feb; 35(2):250-8. PubMed ID: 26858377
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of donor funding for immunization from Gavi and other development assistance channels on vaccine coverage: Evidence from 120 low and middle income recipient countries.
    Ikilezi G; Augusto OJ; Dieleman JL; Sherr K; Lim SS
    Vaccine; 2020 Jan; 38(3):588-596. PubMed ID: 31679863
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Introducing new vaccines in the poorest countries: what did we learn from the GAVI experience with financial sustainability?
    Lydon P; Levine R; Makinen M; Brenzel L; Mitchell V; Milstien JB; Kamara L; Landry S
    Vaccine; 2008 Dec; 26(51):6706-16. PubMed ID: 18952134
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sustainability of National Immunization Programme (NIP) performance and financing following Global Alliance for Vaccines and Immunization (GAVI) support to the Democratic Republic of the Congo (DRC).
    Le Gargasson JB; Breugelmans JG; Mibulumukini B; Da Silva A; Colombini A
    Vaccine; 2013 Apr; 31(15):1886-91. PubMed ID: 23462529
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Charting the evolution of approaches employed by the Global Alliance for Vaccines and Immunizations (GAVI) to address inequities in access to immunization: a systematic qualitative review of GAVI policies, strategies and resource allocation mechanisms through an equity lens (1999-2014).
    Gandhi G
    BMC Public Health; 2015 Nov; 15():1198. PubMed ID: 26621528
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Costs of vaccine programs across 94 low- and middle-income countries.
    Portnoy A; Ozawa S; Grewal S; Norman BA; Rajgopal J; Gorham KM; Haidari LA; Brown ST; Lee BY
    Vaccine; 2015 May; 33 Suppl 1():A99-108. PubMed ID: 25919184
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The GAVI Financing Task Force: one model of partner collaboration.
    Milstien JB; Kamara L; Lydon P; Mitchell V; Landry S
    Vaccine; 2008 Dec; 26(51):6699-705. PubMed ID: 19306508
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Applying lessons learned from the USAID family planning graduation experience to the GAVI graduation process.
    Shen AK; Farrell MM; Vandenbroucke MF; Fox E; Pablos-Mendez A
    Health Policy Plan; 2015 Jul; 30(6):687-95. PubMed ID: 24974106
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Projected health and economic impact of rotavirus vaccination in GAVI-eligible countries: 2011-2030.
    Atherly DE; Lewis KD; Tate J; Parashar UD; Rheingans RD
    Vaccine; 2012 Apr; 30 Suppl 1():A7-14. PubMed ID: 22520139
    [TBL] [Abstract][Full Text] [Related]  

  • 11. What have we learned on costs and financing of routine immunization from the comprehensive multi-year plans in GAVI eligible countries?
    Brenzel L
    Vaccine; 2015 May; 33 Suppl 1():A93-8. PubMed ID: 25919183
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overcoming challenges to sustainable immunization financing: early experiences from GAVI graduating countries.
    Saxenian H; Hecht R; Kaddar M; Schmitt S; Ryckman T; Cornejo S
    Health Policy Plan; 2015 Mar; 30(2):197-205. PubMed ID: 24510369
    [TBL] [Abstract][Full Text] [Related]  

  • 13. World Health Organization perspectives on the contribution of the Global Alliance for Vaccines and Immunization on reducing child mortality.
    Bustreo F; Okwo-Bele JM; Kamara L
    Arch Dis Child; 2015 Feb; 100 Suppl 1():S34-7. PubMed ID: 25613965
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Country Ownership And Gavi Transition: Comprehensive Approaches To Supporting New Vaccine Introduction.
    Shen AK; Weiss JM; Andrus JK; Pecenka C; Atherly D; Taylor K; McQuestion M
    Health Aff (Millwood); 2016 Feb; 35(2):272-6. PubMed ID: 26858380
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lessons learned in shaping vaccine markets in low-income countries: a review of the vaccine market segment supported by the GAVI Alliance.
    Gilchrist SA; Nanni A
    Health Policy Plan; 2013 Dec; 28(8):838-46. PubMed ID: 23174880
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tracking donor funding towards achieving the Global Vaccine Action Plan (GVAP) goals: A landscape analysis (1990-2016).
    Ikilezi G; Zlavog B; Augusto OJ; Sherr K; Lim SS; Dieleman JL
    Vaccine; 2018 Nov; 36(49):7487-7495. PubMed ID: 30366804
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Financial requirements of immunisation programmes in developing countries: a 2004-2014 perspective.
    Peny JM; Gleizes O; Covilard JP
    Vaccine; 2005 Aug; 23(37):4610-8. PubMed ID: 15979769
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of Global Alliance for Vaccines and Immunization (GAVI) in Accelerating Inactivated Polio Vaccine Introduction.
    Thacker N; Thacker D; Pathak A
    Indian Pediatr; 2016 Aug; 53 Suppl 1():S57-S60. PubMed ID: 27771641
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New tendencies and strategies in international immunisation: GAVI and The Vaccine Fund.
    Martin JF; Marshall J
    Vaccine; 2003 Jan; 21(7-8):587-92. PubMed ID: 12531322
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Impact of Conflict on Immunisation Coverage in 16 Countries.
    Grundy J; Biggs BA
    Int J Health Policy Manag; 2019 Apr; 8(4):211-221. PubMed ID: 31050966
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.